Form 4: Repligen CEO Anthony Hunt Sells Shares Under 10b5-1 Trading Plan

Repligen's CEO, Anthony Hunt, executed multiple sales of common stock on May 21, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 21, 2024, Anthony Hunt, the CEO of Repligen Corp (RGEN), sold shares of the company's common stock.
• The sales were executed under a 10b5-1 trading plan adopted on November 9, 2023.
• A total of 22,062 shares were sold in multiple transactions at varying prices.
• The prices ranged from $165.73 to $171.23 per share.
• The weighted average prices for the transactions were between $166.36 and $171.03.
• Following the reported transactions, Hunt directly owns 163,177 shares of Repligen common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine stock sales by the CEO under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company executives are a normal part of corporate governance. The fact that these sales were executed under a 10b5-1 trading plan suggests they were pre-planned and not based on any inside information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.
• The impact on employees, customers, suppliers, and creditors is expected to be minimal.

Key Dates